Skip to the content

RA Thecosystem

Rheumatoid Arthritis

£150 per month

It’s all about seeing who’s who, what they’ve done, who they work with, how they influence.

What’s in a Thecosystem?

Hundreds of guidelines, regulatory & reimbursement reviews and learned societies. 

Thousands of people, experts, influencers, publications, events and clinical trials.

See how everything connects

All the information you need, in one place.
Up to date and instantly useful.

 

People

Over 4100 experts

  • Find profiles of thousands of the experts actively shaping RA
  • Explore professional networks
  • Academics, physicians, policy makers, economists, even patients
  • High-quality information and insights traditionally reserved for senior executives
  • Accurate, complete, up-to-date, referenced and connected

Guidelines

Over 60 including:

  • 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
  • Actualización de la Guía Mexicana para el Tratamiento Farmacológico de la Artritis Reumatoide del Colegio Mexicano de Reumatología (Update of the Mexican College of Rheumatology guidelines for the pharmacologic treatment of rheumatoid arthritis)
  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
  • Consensus-based recommendations for the use of biosimilars to treat rheumatological diseases
  • 関節リウマチ(RA)に対するTNF阻害薬使用ガイドライン (Guidelines for using TNF inhibitors against rheumatoid arthritis (RA))

Regulatory & Reimbursement Organisations

19 including:

  • US Food and Drug Administration (FDA)
  • European Medicines Agency (EMA)
  • National Institute for Health and Care Excellence (NICE)
  • Therapeutic Goods Administration (TGA)
  • Agência Nacional de Vigilância Sanitária (ANVISA) (Brazillian Health Regulatory Agency)

Professional Associations

Over 70 including:

  • American College of Rheumatology (ACR)
  • Asian Pacific League of Associations for Rheumatology (APLAR)
  • Australian Rheumatology Association (ARA)
  • European League Against Rheumatism (EULAR)
  • 日本リウマチ学会 (Japan College of Rheumatology) (JCR)

Patient Advocacy Groups

19 including:

  • National Rheumatoid Arthritis Society (NRAS)
  • Patient Rheumatoid Arthritis Social Support Initiative (PARASS)
  • Rheumatoid Patient Foundation (RPF)
  • Deutsche Rheuma-Liga Bundesverband e.V. (German Rheumatism League)
  • Associação Nacional de Doentes com Artrite Reumatóide (ANDAR)

Journals

Over 200 including:

  • Current Opinion in Rheumatology
  • European Journal of Rheumatology
  • Annals of the Rheumatic Diseases
  • The Journal of Rheumatology
  • Rheumatic Diseases Clinics of North America

Conferences

Over 130 including:

  • 2018 ACR/ARHP Annual Meeting
  • 62nd Annual Scientific Meeting of Japan College of Rheumatology (JCR)
  • 19th Annual European Congress of Rheumatology of European League Against Rheumatism (EULAR)
  • 9th International Forum on Rheumatoid Arthritis (IFRA)
  • 17th Mediterranean Congress of Rheumatology

Clinical Trials

Over 600 including:

  • A Phase 1, Placebo-Controlled, Randomized Study Evaluating the Safety and Pharmacokinetics of GS-4059 in Healthy Volunteers and Subjects with Rheumatoid Arthritis (RA)
  • A Phase 2a, 4-Week Double-Blind, Proof-of-Concept Efficacy and Safety Study of CC-292 Versus Placebo as Co-therapy With Methotrexate in Active Rheumatoid Arthritis
  • A Phase IV Study of Iguratimod in Patients with Active Rheumatoid Arthritis (RA)
  • A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination with Methotrexate Versus Methotrexate Alone in Patients with Rheumatoid Arthritis
  • A Randomized, Double-Blind, Placebo-Controlled Study in Subjects with Rheumatoid Arthritis to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ABBV-257

RA Thecosystem

Rheumatoid Arthritis

£150 per month